These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1429075)

  • 1. Starting therapy for an HIV-infected patient.
    Blais FX
    J Am Osteopath Assoc; 1992 Sep; 92(9):1153-4. PubMed ID: 1429075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing a patient with progressive HIV disease.
    Blais FX
    J Am Osteopath Assoc; 1992 Oct; 92(10):1267-8. PubMed ID: 1459873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple guidelines for HIV testing in the physician's practice.
    Calabrese LH; Condoluci D
    J Am Osteopath Assoc; 1992 Apr; 92(4):499-500. PubMed ID: 1601692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workup of a patient with newly diagnosed HIV infection.
    Condoluci DV
    J Am Osteopath Assoc; 1992 Aug; 92(8):1039-40. PubMed ID: 1429063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to recognize patients at risk or infected with HIV.
    Blais FX
    J Am Osteopath Assoc; 1992 Feb; 92(2):234-5. PubMed ID: 1544828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special considerations for HIV infection in women.
    Tranen BT
    J Am Osteopath Assoc; 1992 Nov; 92(11):1437-8. PubMed ID: 1289314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counseling the patient with newly diagnosed HIV infection.
    Tranen BT
    J Am Osteopath Assoc; 1992 Jun; 92(6):785-6. PubMed ID: 1612944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real risks of HIV transmission to physicians and their staffs. American Osteopathic Association Task Force on AIDS.
    Calabrese L
    J Am Osteopath Assoc; 1992 Jan; 92(1):109-11. PubMed ID: 1559852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The family physician's contribution to the care of patients in the final stages of HIV infection.
    Calabrese LH
    J Am Osteopath Assoc; 1992 Dec; 92(12):1523-4. PubMed ID: 1483882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helping patients to reduce their risk of acquiring sexually transmitted disease.
    Braun JF
    J Am Osteopath Assoc; 1992 May; 92(5):646-7. PubMed ID: 1601700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV).
    J Am Osteopath Assoc; 1996 Jun; 96(6):339. PubMed ID: 8690619
    [No Abstract]   [Full Text] [Related]  

  • 13. Continued zidovudine or didanosine for human immunodeficiency virus infection.
    Behrman RE; Kammerman LA; Feigal DW
    N Engl J Med; 1992 Nov; 327(22):1598-9. PubMed ID: 1435893
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
    Pediatr Infect Dis J; 1993 Jun; 12(6):513-22. PubMed ID: 8393969
    [No Abstract]   [Full Text] [Related]  

  • 15. Using convergent combination therapy, researchers stopped the human immunodeficiency virus (HIV) from reproducing in test tubes.
    J Am Osteopath Assoc; 1993 Apr; 93(4):431. PubMed ID: 8478218
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
    Raboud JM; Montaner JS; Rae S; Kahn J; Hammer SM; Katzenstein DA; Pavia A; Dolin R; Hughes MD; Cross A; Beltangady M; Gatell J; Dunkle L; Smaldone L
    Antivir Ther; 1997 Dec; 2(4):237-47. PubMed ID: 11327443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
    Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
    Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
    Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.